BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 38762063)

  • 1. Reconstruction of Sjögren's syndrome-like sialadenitis by a defined disease specific gut-reactive single TCR and an autoantibody.
    Iizuka-Koga M; Ito M; Yumoto N; Mise-Omata S; Hayakawa T; Komai K; Chikuma S; Takahashi S; Matsumoto I; Sumida T; Yoshimura A
    Clin Immunol; 2024 Jul; 264():110258. PubMed ID: 38762063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biased T cell receptor V beta gene usage during specific stages of the development of autoimmune sialadenitis in the MRL/lpr mouse model of Sjögren's syndrome.
    Hayashi Y; Hamano H; Haneji N; Ishimaru N; Yanagi K
    Arthritis Rheum; 1995 Aug; 38(8):1077-84. PubMed ID: 7639803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenesis of Sjögren's syndrome-like autoimmune lesions in MRL/lpr mice.
    Hayashi Y; Haneji N; Hamano H
    Pathol Int; 1994 Aug; 44(8):559-68. PubMed ID: 7952145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The anergy induction of M3 muscarinic acetylcholine receptor-reactive CD4+ T cells suppresses experimental sialadenitis-like Sjögren's syndrome.
    Asashima H; Tsuboi H; Takahashi H; Hirota T; Iizuka M; Kondo Y; Matsui M; Matsumoto I; Sumida T
    Arthritis Rheumatol; 2015 May; 67(8):2213-25. PubMed ID: 25891013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A crucial role of RORγt in the development of spontaneous Sialadenitis-like Sjögren's syndrome.
    Iizuka M; Tsuboi H; Matsuo N; Asashima H; Hirota T; Kondo Y; Iwakura Y; Takahashi S; Matsumoto I; Sumida T
    J Immunol; 2015 Jan; 194(1):56-67. PubMed ID: 25411202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired Interleukin-27-Mediated Control of CD4+ T Cell Function Impact on Ectopic Lymphoid Structure Formation in Patients With Sjögren's Syndrome.
    Lucchesi D; Coleby R; Pontarini E; Prediletto E; Rivellese F; Hill DG; Derrac Soria A; Jones SA; Humphreys IR; Sutcliffe N; Tappuni AR; Pitzalis C; Jones GW; Bombardieri M
    Arthritis Rheumatol; 2020 Sep; 72(9):1559-1570. PubMed ID: 32307922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early Covert Appearance of Marginal Zone B Cells in Salivary Glands of Sjögren's Syndrome-Susceptible Mice: Initiators of Subsequent Overt Clinical Disease.
    Peck AB; Nguyen CQ; Ambrus J
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of T cell receptor diversity in NOD mice prevents development of type 1 diabetes but not Sjögren's syndrome.
    Kern J; Drutel R; Leanhart S; Bogacz M; Pacholczyk R
    PLoS One; 2014; 9(11):e112467. PubMed ID: 25379761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-120-kDa alpha-fodrin immune response with Th1-cytokine profile in the NOD mouse model of Sjögren's syndrome.
    Yanagi K; Ishimaru N; Haneji N; Saegusa K; Saito I; Hayashi Y
    Eur J Immunol; 1998 Oct; 28(10):3336-45. PubMed ID: 9808203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of T cell receptor repertoire and anti-Ro/SSA autoantibodies in relation to sialadenitis of NOD mice.
    Skarstein K; Wahren M; Zaura E; Hattori M; Jonsson R
    Autoimmunity; 1995; 22(1):9-16. PubMed ID: 8882417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemokines Up-Regulated in Epithelial Cells Control Senescence-Associated T Cell Accumulation in Salivary Glands of Aged and Sjögren's Syndrome Model Mice.
    Kurosawa M; Shikama Y; Furukawa M; Arakaki R; Ishimaru N; Matsushita K
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33669065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of M3 muscarinic acetylcholine receptor reactive T cells in Sjögren's syndrome: a critical review.
    Sumida T; Tsuboi H; Iizuka M; Hirota T; Asashima H; Matsumoto I
    J Autoimmun; 2014 Jun; 51():44-50. PubMed ID: 24397962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implication of Epstein-Barr virus infection in disease-specific autoreactive B cell activation in ectopic lymphoid structures of Sjögren's syndrome.
    Croia C; Astorri E; Murray-Brown W; Willis A; Brokstad KA; Sutcliffe N; Piper K; Jonsson R; Tappuni AR; Pitzalis C; Bombardieri M
    Arthritis Rheumatol; 2014 Sep; 66(9):2545-57. PubMed ID: 24891330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenic role of immune response to M3 muscarinic acetylcholine receptor in Sjögren's syndrome-like sialoadenitis.
    Iizuka M; Wakamatsu E; Tsuboi H; Nakamura Y; Hayashi T; Matsui M; Goto D; Ito S; Matsumoto I; Sumida T
    J Autoimmun; 2010 Dec; 35(4):383-9. PubMed ID: 20864316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ly9 (CD229) Antibody Targeting Depletes Marginal Zone and Germinal Center B Cells in Lymphoid Tissues and Reduces Salivary Gland Inflammation in a Mouse Model of Sjögren's Syndrome.
    Puñet-Ortiz J; Sáez Moya M; Cuenca M; Caleiras E; Lazaro A; Engel P
    Front Immunol; 2018; 9():2661. PubMed ID: 30519241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RORγt antagonist suppresses M3 muscarinic acetylcholine receptor-induced Sjögren's syndrome-like sialadenitis.
    Tahara M; Tsuboi H; Segawa S; Asashima H; Iizuka-Koga M; Hirota T; Takahashi H; Kondo Y; Matsui M; Matsumoto I; Sumida T
    Clin Exp Immunol; 2017 Feb; 187(2):213-224. PubMed ID: 27643385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single cell analysis of T cells infiltrating labial salivary glands from patients with Sjögren's syndrome.
    Matsumoto I; Okada S; Kuroda K; Iwamoto I; Saito Y; Tokuhisa T; Nishioka K; Sumida T
    Int J Mol Med; 1999 Nov; 4(5):519-27. PubMed ID: 10534575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local delivery of AAV2-CTLA4IgG decreases sialadenitis and improves gland function in the C57BL/6.NOD-Aec1Aec2 mouse model of Sjögren's syndrome.
    Yin H; Nguyen CQ; Samuni Y; Uede T; Peck AB; Chiorini JA
    Arthritis Res Ther; 2012 Feb; 14(1):R40. PubMed ID: 22369699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sialadenitis in IQI/Jic mice: a new animal model of Sjögren's syndrome.
    Saegusa J; Kubota H
    J Vet Med Sci; 1997 Oct; 59(10):897-903. PubMed ID: 9362038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of IgM antibody production and repertoire in a mouse model of Sjögren's syndrome.
    Kramer JM; Holodick NE; Vizconde TC; Raman I; Yan M; Li QZ; Gaile DP; Rothstein TL
    J Leukoc Biol; 2016 Feb; 99(2):321-31. PubMed ID: 26382297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.